Clinical Trial Results:
An 8-week randomized, double-blind, placebo-controlled factorial study to evaluate the efficacy and safety of LCZ696 alone and in combination with amlodipine in patients with essential hypertension
Summary
|
|
EudraCT number |
2013-001643-30 |
Trial protocol |
SK ES |
Global completion date |
11 Nov 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1 |
This version publication date |
05 Jan 2017
|
First version publication date |
06 Feb 2019
|
Other versions |
v2 |
Summary report(s) |
CLCZ696A2320 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.